The findings indicate that PSME3 may play a critical role in GC carcinogenesis, and ROC analysis suggested that PSME3 had high diagnostic performance for distinguishing GC patients from healthy individuals and could serve as a novel diagnostic marker for GC. Here, PSME3 is linked to gastric cancer.